Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2025

Apr 3, 2025

30403_dirs_2025-04-03_0de31dbc-f218-45d1-b11b-1f152acf98ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2025-04-01

Reporting Person: Bellet Luc (EVP - Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9474.0000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $135.5700 2027-09-12 Common Stock (710.0000) Direct
Stock Option (Right to Buy) $141.3000 2032-09-20 Common Stock (4636.0000) Direct
Stock Option (Right to Buy) $151.8500 2028-09-18 Common Stock (5175.0000) Direct
Stock Option (Right to Buy) $155.5400 2029-09-17 Common Stock (10927.0000) Direct
Stock Option (Right to Buy) $163.7700 2031-09-21 Common Stock (5612.0000) Direct
Stock Option (Right to Buy) $212.3800 2030-09-22 Common Stock (4039.0000) Direct

Footnotes

F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.

F2: Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026.

F3: Option vests in 4 equal installments - 1/4 on each of the first, second and third anniversaries of the grant date and 1/4 on September 13, 2022.

F4: Option vests in 4 equal installments - 1/4 on each of the first and second anniversaries of the grant date and 1/4 on each of September 13, 2022 and 2023.

F5: Option vests in 4 equal installments - 1/4 on each of October 5, 2022, 2023, 2024 and 2025.

F6: Option vests in 4 equal installments - 1/4 on the first anniversary of the grant date and 1/4 on each of September 13, 2022, 2023, and 2024.